Cargando…
Multivalent designed proteins protect against SARS-CoV-2 variants of concern
Escape variants of SARS-CoV-2 are threatening to prolong the COVID-19 pandemic. To address this challenge, we developed multivalent protein-based minibinders as potential prophylactic and therapeutic agents. Homotrimers of single minibinders and fusions of three distinct minibinders were designed to...
Ejemplares similares
-
Multivalent designed proteins neutralize SARS-CoV-2 variants of concern and confer protection against infection in mice
por: Hunt, Andrew C., et al.
Publicado: (2022) -
Ultrapotent miniproteins targeting the receptor-binding domain protect against SARS-CoV-2 infection and disease in mice
por: Case, James Brett, et al.
Publicado: (2021) -
De novo design of picomolar SARS-CoV-2 miniprotein inhibitors
por: Cao, Longxing, et al.
Publicado: (2020) -
Ultrapotent miniproteins targeting the SARS-CoV-2 receptor-binding domain protect against infection and disease
por: Case, James Brett, et al.
Publicado: (2021) -
Massively parallel protein-protein interaction measurement by sequencing (MP3-seq) enables rapid screening of protein heterodimers
por: Baryshev, Alexander, et al.
Publicado: (2023)